2-[18F]-fluoro-2-desoxy-D-glucose positron emission tomography initial staging impacts on survival in Hodgkin lymphoma

Table 1 Clinical characteristics of 267 patients with newly diagnosed hodgkin lymphoma n (%)

Characteristics	Era 1 150 patients AS	Era 2 117 patients MS	P
Gender
Male	82 (54.7)	63 (52.5)	0.89
Age, median ± SD	33.4 ± 15.1	34.1 ± 16.1	0.25
Pathological subtype
Nodular sclerosis	88 (58.7)	71 (59.2)
Non classified	17 (11.3)	22 (18.3)
Mixed cellularity	31 (20.7)	12 (10.0)	0.53
Lymphocyte predominance	12 (8.0)	9 (7.5)
Lymphocyte depleted	2 (1.3)	6 (5.0)
B symptoms	99 (66.0)	76 (65.0)	0.85
Bulky disease (> 7 cm)	91 (60.3)	67 (57.3)	0.74
Clinical stage			0.12
I	12 (8.0)	9 (7.7)
II	61 (40.7)	45 (38.5)
III	35 (23.3)	27 (23.1)
IV	42 (28.0)	36 (30.8)
Treatment failure	43 (28.7)	36 (30.8)	0.70
Death	20 (13.3)	14 (12.0)	0.73

AS: Anatomical staging; MS: Metabolic staging.